Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    Invitrogen™ CAR Polyclonal Antibody
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547364
Description
In direct ELISAs and Western blots, approximately 35% cross-reactivity with recombinant human CXADR is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
The protein encoded by this gene is a type I membrane receptor for group B coxsackieviruses and subgroup C adenoviruses. Pseudogenes of this gene are found on chromosomes 15, 18, and 21.
            Specifications
| CAR | |
| Polyclonal | |
| Unconjugated | |
| CXADR | |
| 2610206D03Rik; 46 kD coxsackievirus and adenovirus receptor (CAR) protein; AU016810; AW553441; CAR; Car1; CAR4/6; coxsackie virus and adenovirus receptor; coxsackievirus and adenovirus receptor; Coxsackievirus and adenovirus receptor homolog; coxsackievirus B-adenovirus receptor; CVB3-binding protein; Cxadr; HCAR; HCVADR; MCAR; MCVADR; rCAR | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 13052 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized | 
| Immunohistochemistry, Western Blot | |
| 0.2 mg/mL | |
| PBS with 5% trehalose and No Preservative | |
| P97792 | |
| CXADR | |
| Mouse myeloma cell line NS0-derived recombinant mouse CXADR Leu20-Gly237. | |
| 100 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction